Skip to main content

Table 4 Adjusted mean levels of FEV1/FVC(%) by quartile of inflammatory biomarkers and associations per IQR change

From: FEV1 and FVC and systemic inflammation in a spinal cord injury cohort

CRP (mg/L)

 

Q1

(0.07–0.99)

Q2

(1.00–2.41)

Q3

(2.42–6.91)

Q4

(6.92–161.56)

p-for trend

β (95% CI) FEV1/FVC per 5.91 mg/L CRP

p-value

N

77

78

78

78

311

311

311

Basica

76.0 (73.8, 78.2)

77.2 (75.0, 79.4)

76.2 (74.0, 78.4)

78.4 (76.2, 80.6)

0.14

−0.068 (−0.536,0.40)

0.78

Fully adjusted

76.4 (74.1, 78.7)

77.3 (75.2, 79.3)

76.3 (74.3, 78.4)

77.8 (75.6, 79.9)

0.43

−0.19 (−0.643,0.262)

0.41

Parsimonious adjustedb

76.8 (74.7, 79.0)

77.3 (75.3, 79.4)

76.0 (74.0, 78.1)

77.6 (75.5, 79.6)

0.59

−0.216 (−0.65,0.217)

0.33

IL-6 (pg/mL)

 

Q1

(0.30–1.26)

Q2

(1.27–2.12)

Q3

(2.13–4.44)

Q4

(4.45–46.8)

p-for trend

β (95% CI) FEV1/FVC per 3.18 pg/mL IL-6

 

N

77

83

76

75

311

311

311

Basica

77.6 (75.3, 79.8)

76.9 (74.7, 79.0)

77.1 (74.9, 79.4)

76.2 (74.0, 78.5)

0.47

−0.13 (−0.859,0.599)

0.73

Fully adjusted

77.5 (75.3, 79.7)

76.6 (74.6, 78.6)

77.5 (75.4, 79.6)

76.2 (74.0, 78.4)

0.50

0.069 (−0.654,0.791)

0.85

Parsimonious adjustedb

77.9 (75.8, 79.9)

76.5 (74.5, 78.4)

77.4 (75.3, 79.5)

76.1 (74.0, 78.2)

0.38

−0.041 (−0.726,0.645)

0.91

  1. aAdjusted for age, sex, and race
  2. bAdjusted for age, sex, race, smoking status and pack-years, marijuana smoking status, COPD or asthma, current use of steroids and long-acting bronchodilators, level/severity of injury (LOI), and wheelchair use